Thursday, May 28, 2020

How to Corona Treatment from the Homeopathic + Ayurveda

Top 2 treatment of corona :

Coronavirus is a common virus which causes colds, influenza-like symptoms and pneumonia. COVID-19 is a new strain which means fewer people already have immunity to it. It appears to have the most severe effect on the elderly and people with existing medical conditions – particularly those with respiratory problems. There are no standard scientific trials available for homeopathic, or ayurvedic treatment of this coronavirus strain.


Top 2 treatment of corona


Homeopathic Medicine -COVID – 19


Homeopathic medicines have been used extensively for flu-like symptoms and in epidemics around the world. If you decide to take a homeopathic medicine, this should be in addition to the various measures and should not be your only approach. Selection of the most appropriate homeopathic medicine is based on an individual’s unique symptoms. However, Gelsemium 30c and Bryonia 30c are commonly used for flu-like symptoms and have a long-established, traditional usage over many years.

The AYUSH ministry India recommended that homeopathic medicine Arsenicum album 30 could be taken empty stomach daily for three days as a prophylactic medicine against the infection. The Ayush Ministry declared Arsenicum Album-30 as a "preventive' against COVID-19. On the basis of research done by Dr Rajan Sankaran, has backed Camphor 1M as a potential medicine for COVID-19.



Ayurvedic Medicine -COVID – 19


Ministry of Ayush starts clinical trials for Ashwagandha and 4 other Ayurvedic herbs for coronavirus treatment. In a recent positive development, Ministry of Ayush, in collaboration with the Council of Scientific & Industrial Research (CSIR) has started clinical trials testing formulation of four important Ayurvedic herbs in fighting the novel coronavirus. The medicines under study include ashwagandha, guduchi, yasthimadhu, peepli and another formulated drug, 'Ayush 64'.

Also Read : 
Phase-3 clinical trials on antiviral drug Favipiravir for COVID-19 by Glenmark in India



No comments: